Condylomata Acuminata Clinical Trial
Official title:
Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population
The summary of this study is to know which HPV types are present in genital warts in Argentinean population.
This is a prospective study. Patients will be evaluated for the presence of external
anogenital warts in our clinic. Biopsy will be performed if patients have genital lesions
consistent with genital warts of the external genitalia or perianal area. All patients will
be provided with an informed consent for the excision biopsy procedure, before performing
the biopsy of the lesion. Biopsy specimens will be held in a formol 10% solution and will be
sent to the pathologist. A portion of each sample will be processed for histological
analysis, which will be performed by one pathologist. The remainder of each specimen will be
saved to extract DNA for PCR analysis. All biopsies will be analyzed by the same pathologist
who will confirm the histology of the lesion. A part of the specimen will be kept frozen and
if the biopsy confirm genital warts by histology; then the specimen will be analyzed by PCR
for the presence of DNA HPV 6 and 11. The PCR analysis will be done by microarrays.
Detection is performed in a subtype of array platform system which detects the different
types of virus. The reports will be as undetectable / detectable and type.
The study will be conducted in the Institute of Gynecology and Fertility (Institute
affiliated with the School of Medicine - University of Buenos Aires).
Chronogram of activities: all activities will be done in a maximum of 60 days
1. st visit: detect external genital warts and firm informed consent and take the biopsy
2. nd visit: inform the result
;
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04537156 -
Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
|
Phase 3 | |
| Completed |
NCT00090285 -
An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020)
|
Phase 3 | |
| Completed |
NCT00973856 -
Evaluation of the Effectiveness of an Alcohol Based Hand Gel for the Reduction of Warts on the Hands
|
N/A | |
| Completed |
NCT02015260 -
A Trial of the Efficacy and Safety of Topical Nitric Oxide in Patients With Anogenital Warts
|
Phase 2 | |
| Active, not recruiting |
NCT05056402 -
An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old
|
Phase 3 | |
| Withdrawn |
NCT00365443 -
Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003)
|
Phase 2 | |
| Not yet recruiting |
NCT01483794 -
Epidemiology, Costs and Psychosocial Consequences of Genital Warts in Valparaiso, Chile
|
N/A | |
| Completed |
NCT03935204 -
Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
|
Phase 2 | |
| Completed |
NCT02405520 -
Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine
|
Phase 1 | |
| Active, not recruiting |
NCT02710851 -
Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine
|
Phase 2 | |
| Completed |
NCT04782895 -
Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age
|
Phase 3 | |
| Completed |
NCT03546842 -
Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017)
|
Phase 3 | |
| Completed |
NCT03981822 -
A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts
|
Phase 2 | |
| Recruiting |
NCT03158480 -
Safety and Efficacy of Immune Therapy for Condyloma
|
N/A | |
| Completed |
NCT00449982 -
Efficacy and Safety Study of Polyphenon E to Treat External Genital Warts
|
Phase 3 | |
| Completed |
NCT03813940 -
Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
|
Phase 1 | |
| Not yet recruiting |
NCT06197802 -
Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women
|
||
| Completed |
NCT01532102 -
Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT06297187 -
Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study
|
||
| Not yet recruiting |
NCT03853785 -
Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital Warts
|
Phase 3 |